Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
32.42
-0.97 (-2.91%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Crinetics Pharmaceuticals Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Crinetics Pharmaceuticals stock have an average target of 73.36, with a low estimate of 54 and a high estimate of 97. The average target predicts an increase of 126.28% from the current stock price of 32.42.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $54 $73.36 $73 $97
Change +66.56% +126.28% +125.17% +199.20%
* Price targets were last updated on Mar 25, 2025.

Analyst Ratings

The average analyst rating for Crinetics Pharmaceuticals stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 334444
Buy 777777
Hold 000111
Sell 000000
Strong Sell 000000
Total 101011121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stifel
Stifel
Strong Buy
Initiates
$60
Strong Buy Initiates $60 +85.07% Mar 25, 2025
Citizens Capital Markets
Citizens Capital Markets
Buy
Maintains
$92$91
Buy Maintains $92$91 +180.69% Feb 28, 2025
Wolfe Research
Wolfe Research
Hold
Initiates
n/a
Hold Initiates n/a n/a Feb 4, 2025
Jefferies
Jefferies
Strong Buy
Upgrades
$55
Strong Buy Upgrades $55 +69.65% Jan 22, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$81
Strong Buy Reiterates $81 +149.85% Jan 13, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
4.74M
from 1.04M
Increased by 356.40%
Revenue Next Year
37.95M
from 4.74M
Increased by 700.38%
EPS This Year
-4.18
from -3.69
EPS Next Year
-4.48
from -4.18
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
71.00K1.08M4.74M4.01M1.04M4.74M37.95M192.88M
Revenue Growth
-94.05%1,418.31%339.43%-15.28%-74.11%356.40%700.38%408.19%
EPS
-2.42-2.80-3.15-3.69-3.69-4.18-4.48-3.38
EPS Growth
--------
Forward PE
--------
No. Analysts
-----171610
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 10.5M 52.1M 338.6M
Avg 4.7M 38.0M 192.9M
Low 1.4M 24.6M 95.6M

Revenue Growth

Revenue Growth 20252026202720282029
High
910.6%
998.3%
792.2%
Avg
356.4%
700.4%
408.2%
Low
32.1%
419.0%
151.8%

EPS Forecast

EPS 20252026202720282029
High -3.03 -2.53 -0.80
Avg -4.18 -4.48 -3.38
Low -5.00 -6.05 -5.18

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.